AbbVie won’t enforce patents for COVID-19 drug candidate KaletraAbbVie has said it won’t defend patent rights to its HIV therapy Kaletra in the hope that it Share XAbbVie won’t enforce patents for COVID-19 drug candidate Kaletrahttps://pharmaphorum.com/news/abbvie-wont-enforce-patents-for-covid-19-drug-candidate-kaletra/
AbbVie’s Kaletra doesn’t work in COVID-19, say Chinese scientistsA clinical trial of AbbVie’s HIV therapy Kaletra conducted by researchers in China has undermined hopes it could Share XAbbVie’s Kaletra doesn’t work in COVID-19, say Chinese scientistshttps://pharmaphorum.com/news/abbvies-kaletra-doesnt-work-in-covid-19-say-chinese-scientists/
